Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 78 clinical trials
HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).

mastectomy and 40Gy/16/3wks after breast conserving surgery (BCS).It is also a routine practice in the UK and in a few centers in Canada. Hypofractionation reduces treatment time to half while

carcinoma
adjuvant chemotherapy
mastectomy
invasive carcinoma
breast-conserving surgery
  • 0 views
  • 01 Jul, 2021
  • 1 location
De-Escalation of Adjuvant Chemotherapy in HER2-positive, Estrogen Receptor-negative, Node-negative Early Breast Cancer Patients Who Achieved Pathological Complete Response After Neoadjuvant Chemotherapy and Dual HER2 Blockade (Decrescendo)

radiotherapy will be mandatory after breast-conserving surgery, whereas it will be performed according to local guidelines after mastectomy, and it will be administered concomitantly with pertuzumab and

  • 0 views
  • 22 Oct, 2022
  • 39 locations
The Postoperative Radiotherapy in N1 Breast Cancer Patients (PORT-N1)

This study is a multicenter, randomized, phase 3 clinical trial in patients with breast cancer, randomizing radiotherapy group (postmastectomy radiation therapy (PMRT)/whole breast irradiation plus regional radiotherapy (WBI+regional RT) versus and no PMRT/WBI alone group. This is a non-inferiority study aiming that there is no significant difference in the 7-year …

growth factor
epidermal growth factor receptor
breast-conserving surgery
invasive breast cancer
EGFR
  • 0 views
  • 07 Oct, 2022
  • 1 location
Fluorescence Imaging of Carcinoma During Breast Conserving Surgery

Breast conserving surgery (BCS) is performed on patients with breast cancer to resect and completely remove the cancer while conserving as much of the surrounding healthy tissue as possible

carcinoma
ductal carcinoma in situ
lobular carcinoma
breast-conserving surgery
lumpectomy
  • 0 views
  • 07 Oct, 2022
  • 3 locations
Endoscopic Breast Conserving Surgery With Intra-operative Navigation System

A growing number of Chinese breast cancer patients are diagnosed at a young age. The quality of life of young breast cancer patients has been a critical issue. Breast-conserving surgery (BCS

breast surgery
breast cancer
cancer
  • 0 views
  • 04 Oct, 2022
  • 1 location
Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor

The investigators will perform this study to prospectively compare the clinical outcome after percutaneous microwave ablation(MWA) and breast conserving surgery of benign and malignant breast

carcinoma
breast cancer
cancer
metastasis
breast-conserving surgery
  • 0 views
  • 31 Oct, 2021
  • 1 location
Lidocaine Mucilage-ICG as an Optical Agent for Tumor Delineation During Breast-conserving Surgery

Around 15%-30% of patients receiving breast-conserving surgery (BCS) for invasive breast carcinoma or ductal carcinoma in situ (DCIS) need a reoperation due to tumor-positive margins at final

carcinoma
carcinoma in situ
ductal carcinoma in situ
breast-conserving surgery
invasive breast cancer
  • 0 views
  • 26 Jan, 2021
  • 1 location
Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation in Early Breast Cancer After Breast-conserving Surgery

Radiotherapy has been confirmed as an important treatment breast-conserving surgery reducing the risk of any recurrence of breast cancer and breast cancer-related mortality in patients with

  • 0 views
  • 18 Mar, 2021
  • 1 location
Assessing the Rate of Complications in X-Ray Therapy Versus Proton Beam Radiation Therapy After Breast Conserving Surgery or Mastectomy in Treating Patients With Breast Cancer

This phase II trial investigates the rate of complications of x-ray therapy versus proton beam radiation therapy after breast conserving surgery or mastectomy in treating patients with breast

tumor cells
proton beam radiation therapy
mastectomy
cancer
  • 5 views
  • 17 Jun, 2022
  • 3 locations
Multi-institutional Study to Increase Breast Conserving Surgery (BCS) Rate With Personalized Neoadjuvant Strategy in ER Positive and HER2 Negative Breast Cancer Patients for Whom BCS is Not Feasible

In ER+ and HER2- breast cancer(BC) patients for whom BCS is not feasible, we investigate the rate of BCS can be increased while decreasing unnecessary chemotherapy thru selective neoadjuvant chemotherapy or neoadjuvant endocrine therapy using tools of nodal status, Ki-67, and multigene assay(Mammaprint)

endocrine therapy
metastasis
ki-67
breast-conserving surgery
erbb2
  • 0 views
  • 27 Oct, 2022
  • 1 location